M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Barceló C, Sisó P, de la Rosa I, Megino-Luque C, Navaridas R, Maiques O, Urdanibia I, Eritja N, Soria X, Potrony M, Calbet-Llopart N, Puig S, Matías-Guiu X, Martí RM, Macià A.
Barceló C, et al. Among authors: calbet llopart n.
Br J Cancer. 2022 Oct;127(6):1142-1152. doi: 10.1038/s41416-022-01886-4. Epub 2022 Jun 20.
Br J Cancer. 2022.
PMID: 35725813
Free PMC article.